We have developed a novel ring-opening difluorination process for pyrazoloazines. Utilizing 2.5 equivalents of Selectfluor®, this method enables electrophilic difluorination and subsequent ring-opening of pyrazoloazines, yielding the corresponding difluoroalkylated azines. Additionally, our protocol extends to the decarbonylative difluorination of pyrazoloazines when starting with a formyl group at the C3 position, demonstrating the versatility and broad applicability of this approach. This advancement in difluorination chemistry offers a new pathway for the synthesis of difluorinated compounds, potentially enriching the toolkit for practitioners in medicinal chemistry and materials science.
No takes yet. Share an insight, caveat, or question.
Ohki et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: